Navigation Links
Health Drink Blamed for Persistent Penile Erection

On June 5, 2004, Christopher Woods, a 29-year old resident in New York, drank Boost Plus, a vitamin enriched beverage, made by the Swiss-based Novartis Pharmaceutical company.

When he woke up the next day, he had an erection that would not go away. He had to go for medical advice and for treatment of the condition called severe priapism, according to his court papers.

Priapism is persistent, painful erection of the penis. Recurrent or severe episodes can result in future impotence. Treatment is often not satisfactory.

According to the lawsuit filed recently, a surgery for implantation of a Winter shunt was performed to move blood from one area to another. Later, he had problems and had to be hospitalised briefly for penile artery embolisation, a procedure to close off blood vessels to lessen the likelihood of an erection.

In his lawsuit, that sought unspecified damages, he has named Novartis Consumer Health Inc as a defendant. The advertisements for Boost Plus describe the drink as a ``great tasting, high calorie, nutritionally complete oral supplement for people requiring extra energy and protein in a limited volume''. Boost Plus is available in vanilla, chocolate and strawberry.

The company is aware of the lawsuit, accepted a spokesperson unwilling to comment on the litigation pending before the courts.


'"/>




Page: 1

Related medicine news :

1. Startling Expose – Physicians Often Have No Regular Source Of Health Car
2. Want a Healthy brew? Have some Tea!
3. Healthcare sector is now a multi billion-dollar industry in India
4. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
5. Health at heights
6. Health Officials Recommend Flu Vaccine
7. Slightly High BP Poses Health Risk
8. Unsatisfactory Grade On Womens Health Issues
9. Iodex goes to SmithKline Beecham consumer Healthcare
10. Healthy Medicine Or Harmful Intoxicant?
11. Healthy snacks improve nutrition of kids
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
Breaking Medicine Technology: